MEDPLUS

Medplus Health Services Financial Results

₹645.15-0.97%
Market cap
₹7,742 crore
P/E
36.8
P/B
3.92
ROE
11.8%
Dividend yield
1.20%

For the year ended Mar 2022, Medplus Health Services reported revenue of ₹3,779 crore and net profit of ₹95 crore, against ₹4,529 crore and ₹50 crore a year earlier.

Medplus Health Services annual profit and loss

Financial years, newest first. TTM = trailing twelve months.

Medplus Health Services annual profit and loss (₹ crore)
ItemMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue3,7794,5295,5746,0876,8357,172
Expenses3,5074,2605,2185,5836,2106,544
Operating profit272269356505626628
Operating margin %7%6%6%8%9%9%
Other income314338315358
Interest668396103120126
Depreciation119182224250283295
Profit before tax1184773183275264
Tax %20%-6%11%18%20%20%
Net profit955066150220210
EPS (₹)8.054.185.4812.5618.3017.54
Dividend payout %——————

Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.

Medplus Health Services financial results — frequently asked questions

What is Medplus Health Services' annual revenue and net profit?

For the financial year ended Mar 2022, Medplus Health Services' revenue was ₹3,779 crore and net profit ₹95 crore; net profit rose 90.00% from ₹50 crore in Mar 2023.

How fast has Medplus Health Services grown over three years?

From Mar 2025 to Mar 2022, Medplus Health Services' revenue grew at a compound annual rate of -14.7% and net profit at -14.1%. Past growth does not indicate future results.

What is the EPS of Medplus Health Services?

Annual EPS for Mar 2022 was ₹8.05.

Are these figures consolidated or standalone?

They are consolidated figures as reported by the company, in ₹ crore. Trailing-twelve-month and half-year columns are labelled separately and are not counted as financial years.

Same Data For Peers

Trade Medplus Health Services With ATS

Track MEDPLUS live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.